Official title and information are available only for Plus and Premium subscribers.
Patent Granted Dysfunction of dopaminergic neurotransmission in the CNS has been implicated in a variety of neuropsychiatric disorders, including social phobia,[17] Tourette's syndrome,[18] Parkinson's disease,[19] schizophrenia,[18] neuroleptic malignant syndrome,[20] attention-deficit hyperactivity disorder (ADHD),[21] and drug and alcohol dependence.
To see the additional information details please login and subscribe to a Plus or Premium account.
